174P A real-world study of PD-1 inhibitors combined with TKIs for HCC with major vascular invasion as the conversion therapy: A prospective, non-randomized, open-label cohort study

Autor:	Bingyang Hu, G. Ma, Wenwen Zhang, Hongguang Wang, Junning Cao, Huiyi Ye, Shou-wang Cai, Shichun Lu, Yanshuang Cheng, Jun Han, Xun Wang, Zizheng Wang, Meixia Chen
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty business.industry Internal medicine medicine Hematology Conversion therapy Open label business Vascular invasion Cohort study
Zdroj:	Annals of Oncology. 31:S1307
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2020.10.195
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4eb4e2cad7a60df10f3d4c46cc773cef https://doi.org/10.1016/j.annonc.2020.10.195 Zobrazit plný text záznamu